Home
Arch Venture Fund X Overage, 10% Owner: Neumora Therapeutics NMRA Buy · Filed 23/09/20
Trade details
- Type
- Insider buy
- Amount
- $25,500,000
- Shares · price
- 1,500,000 sh · $17.00 a share
- Held after
- 3,624,143 sh
- Trade date
- 23/09/19
- Filed
- 23/09/20
- Days to filing
- 1 days
20 insiders bought this week
- Insiders buying this week
- 20 insiders
- Holding change
- +70.6%
Neumora Therapeutics trades, last 26 weeks
What else happened in Neumora Therapeutics around then
Filed or reported within 30 days of the trade day · 23/08/20~23/10/19Arch Venture Fund X Overage's recent trades
- Arch Venture Fund X Overage
BuyNeumora Therapeutics
BuyNeumora Therapeutics
NMRA
$5M
1,915,700 sh
$5M
Filed 25/10/29
Traded 25/10/27
- Arch Venture Fund X Overage
BuyPrime Medicine
BuyPrime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
- Arch Venture Fund X Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$2.1M
133,333 sh
$2.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund X Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$1.1M
66,667 sh
$1.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund X Overage
BuyPrime Medicine
BuyPrime Medicine
PRME
$20M
3,200,000 sh
$20M
Filed 24/02/20
Traded 24/02/15
